Neuraxis, Inc. (NRXS) intrinsic value & 10-year financials
Neuraxis, Inc. (NRXS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 5 fiscal years revenue grew 10.0% a year to $3.6M, with an average return on invested capital of 452.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $7.70
- Market cap
- $69.9M
- Revenue (FY2025)
- $3.6M
- Revenue growth (5-yr CAGR)
- 10.0%
- ROIC (10-yr avg)
- 452.2%
- Free cash flow (FY2025)
- -$6.5M
NRXS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.6M | -$7.8M | -$0.95 | -$6.5M | -219.4% | 641.1% |
| FY2024 | $2.7M | -$8.2M | -$1.22 | -$6.1M | -266.5% | 652.8% |
| FY2023 | $2.5M | -$14.6M | -$4.50 | -$6.7M | -270.9% | 428.3% |
| FY2022 | $2.7M | -$4.8M | -$2.77 | -$2.3M | -125.6% | 86.6% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Neuraxis, INC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Neuraxis, INC has earned high returns on invested capital, averaging 25.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Neuraxis, INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Neuraxis, INC is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-20.08 per share.